Tag: end-stage renal disease
First successful implantation in Greece for VasQ external support device
The first implantation of the VasQ external support device was performed in Greece, Laminate Medical Technologies announced in a press release. The procedure was...
ESKD Summit 2023: What matters to patients gains momentum with input...
This advertorial is sponsored by BD.
Focusing on the disease through the patient’s lens, establishing well-functioning multidisciplinary teams, to potentially enhance both the patient’s journey...
Vascular Therapies initiates enrolment in ACCESS 2 clinical trial
Vascular Therapies has announced that the first patient in the ACCESS 2 clinical trial was enrolled by Nikhil Kansal at Harbor-UCLA Medical Center in Torrance, USA.
The...
Fresenius Medical Care North America introduces first single-use integrated bloodline to...
Fresenius Medical Care North America's (FMCNA) Renal Therapies Group recently announced the availability of the CombiSet Smartech. According to a company press release, this...
Humacyte announces publication of positive long-term follow-up data from phase 2...
Humacyte today announced that five-year data from a phase 2 clinical trial of patients receiving the investigational Human Acellular Vessel (HAV) for arteriovenous (AV)...
Alio and Lifeline create partnership for dialysis access patient monitoring
Alio has announced a partnership with Lifeline Vascular Care in support of patients living with end-stage renal disease (ESRD). Alio leverages artificial intelligence (AI)...
CMS takes “decisive steps” to reduce healthcare disparities among kidney disease...
The Centers for Medicare & Medicaid Services (CMS) is taking action to close health equity gaps by providing Medicare patients living with end-stage renal...
Fresenius and Cigna expand efforts to help people living with kidney...
Fresenius Medical Care North America (FMCNA) and Cigna have announced an expansion of their national effort to improve health outcomes and lower the cost...
Monogram Health raises US$160 million in funding to accelerate “next-generation” kidney...
Monogram Health, a benefit management and care delivery company attempting to transform care for individuals with chronic kidney disease (CKD) and end-stage renal disease...
Baxter gains FDA clearance for next-generation AK 98 dialysis machine
American healthcare firm and global renal care innovator Baxter International has announced US Food and Drug Administration (FDA) 510(k) clearance of its next-generation Artificial...
XO Score scoring sheath platform gains CE mark to treat PAD...
Transit Scientific has announced CE mark clearance for its XO Score scoring sheath platform, allowing the technology to be used in the treatment of...
BD gains FDA 510(k) clearance for Pristine long-term haemodialysis catheter
American medical technology company BD (Becton, Dickinson and Company) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Pristine...
Multicentre trial of haemodialysis access strategies in older patients deemed feasible...
A multicentre clinical trial to assess arteriovenous fistula (AVF)-first and arteriovenous graft (AVG)-first access strategies in older end-stage renal disease (ESRD) patients on haemodialysis...
Cricket Health announces new kidney care programme for late-stage CKD and...
Cricket Health has announced a new kidney care programme specifically designed for late-stage chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients enrolled...
“More creative solutions” needed for end-stage vascular access patients
Nicholas (Nick) Inston calls for “more creative solutions” to vascular access challenges, commending interventional radiologists’ innovative reputation as instrumental to increasing the number of...